Plant metabolite content regulator
A plant metabolite regulator with diacetylene compounds enhances the production of functional components like glycyrrhizin and fatty acids in plants, addressing resource scarcity and environmental stress, thereby improving their functional properties.
Patent Information
- Application Number
- JP2023082037
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-18
- Publication Date
- 2024-11-28
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The challenge is to efficiently increase the production of plants with high functional components, such as terpenoids, sulfur compounds, and fatty acids, while addressing issues of resource scarcity and environmental stress responses, which are not adequately resolved by existing cultivation methods like hydroponic cultivation.
A plant metabolite content regulator containing compounds with a diacetylene structure is used to modulate the production of metabolites in plants, enhancing their functional component content through targeted application.
The regulator effectively increases the content of metabolites like glycyrrhizin, terpenoids, and fatty acids in plants, improving their functional properties without significant changes in plant weight.
Smart Images

Figure 2024165664000021 
Figure 2024165664000022 
Figure 2024165664000023
Abstract
Description
[Technical field]
[0001] The present disclosure relates to a plant metabolite content regulator, etc. [Background technology]
[0002] Currently, most of the functional plants used in Japan are imported from overseas, but the amount of resources that Japan can secure is decreasing due to the decline in wild resources caused by changes in the natural environment. Furthermore, it is becoming increasingly difficult to secure stable functional plant resources due to the strengthening of international regulations on the protection of genetic resources. On the other hand, in an aging society, it is desired to extend healthy lifespan from the perspective of QOL, and to implement preventive care to reduce medical and nursing care costs from the perspective of medical economics, and it is expected that the demand for medicinal plants and functional food ingredients will further increase in the future. In response to this situation, various efforts are being made in Japan to increase the self-sufficiency rate of the country, but the self-sufficiency rate has not improved sufficiently due to problems such as the aging of growers and low profitability. In recent years, new cultivation research such as hydroponic cultivation has been conducted to solve these problems, but there are many issues that cannot be solved by only examining cultivation conditions such as light, irrigation, and fertilization in order to efficiently increase the production of plants with high functional ingredient content.
[0003] Many of the metabolites that are considered to be the active ingredients of medicinal plants and functional food ingredients are thought to be produced primarily for stress resistance and defense. Therefore, in order to improve the quality of medicinal plants and functional food ingredients, it is reasonable to understand and utilize the response functions of plants to the environment, such as interactions with other plants. [Prior art documents] [Patent documents]
[0004] [Patent Document 1] Patent No. 4686716 Summary of the Invention [Problem to be solved by the invention]
[0005] A preventive approach that utilizes the normal food intake process would allow for continuous daily intake of functional ingredients in a natural form by enhancing the functional ingredients of plants. In addition, a preventive approach that utilizes effective herbal medicines and herbal medicines would be effective. From these perspectives, the production of plants with high functional ingredient content is desirable.
[0006] On the other hand, plants have a mechanism for regulating the amount of metabolites in response to external stimuli. Many functional components such as terpenoids, sulfur compounds, and fatty acids are known as metabolites, and it is believed that plants with high functional component content can be obtained by regulating the content of these components.
[0007] Patent Document 1 reports a technique for adjusting the metabolite content by irradiating a plant with light of a specific wavelength and UV-B irradiation. However, this technique requires a device for irradiating light with an adjusted wavelength, and cannot be used easily.
[0008] An objective of the present disclosure is to provide an agent for regulating metabolite content in plants. [Means for solving the problem]
[0009] In view of the above problems, the present inventors have conducted intensive research and found that a compound having a diacetylene structure in which two ethynylene groups are arranged side by side has activity of regulating metabolite content in plants. Based on this finding, the present inventors have conducted further research and completed the present invention. That is, the present disclosure includes the following aspects.
[0010] Section 1. General formula (1):
[0011] TIFF2024165664000001.tif13170 [In the formula: R1 represents a hydrocarbon group which may be partially replaced by an ester group, a carbonyl group, or an oxygen atom. R2 represents a hydrocarbon group which may be partially replaced by an ester group, a carbonyl group, or an oxygen atom.] A plant metabolite content regulator comprising at least one compound selected from the group consisting of compounds represented by the following formula (I):
[0012] Section 2. The compound has the general formula (2):
[0013] TIFF2024165664000002.tif27170 [wherein R2 is the same as above. R 11 , R 12 , R 13 R represents a hydrocarbon group which may be partially substituted with an ester group, a carbonyl group or an oxygen atom, or a hydrogen atom. 11 and R 13 may be bonded to form a ring. Item 2. The plant metabolite content regulator according to Item 1, comprising at least one compound selected from the group consisting of compounds represented by the formula:
[0014] Section 3. R 11 and the above R 13 is an alicyclic hydrocarbon group when bonded to form a ring.
[0015] Section 4. The compound has the general formula (3):
[0016] TIFF2024165664000003.tif21170 [wherein R2 is the same as above. R 111 R represents an alkyl group. 21 represents a hydrocarbon group which may be partially substituted with an ester group, a carbonyl group, or an oxygen atom. 4. The metabolite content regulator according to any one of items 1 to 3, which is a compound represented by the following formula:
[0017] Section 5. The compound has the general formula (4):
[0018] TIFF2024165664000004.tif23170[in formula:R 111 R represents an alkyl group.22 represents a hydrocarbon group partially substituted with an ester group, or an alkyl group. 5. The metabolite content regulator according to any one of items 1 to 4, wherein the compound is represented by the formula:
[0019] Section 6. The compound has the general formula (5):
[0020] TIFF2024165664000005.tif25170[in formula:R 111 R represents an alkyl group. 221 represents a linear unsaturated hydrocarbon group. 6. The metabolite content regulator according to any one of items 1 to 5, wherein the compound is represented by the formula:
[0021] Section 7. Item 7. The metabolite content regulator according to any one of Items 1 to 6, wherein the compound is a plant-derived substance.
[0022] Section 8. 8. The metabolite content regulator according to any one of Items 1 to 7, wherein the plant-derived substance is any one of a substance derived from a plant of the genus Goldenrod, a plant of the genus Ophiopogon, and a plant of the genus Artemisia.
[0023] Section 9. Item 9. The metabolite content regulator according to any one of Items 1 to 8, wherein the metabolite is at least one selected from the group consisting of terpenoid compounds, sulfur compounds, and glycosides thereof, and fatty acids.
[0024] Section 10. Item 10. The metabolite content regulator according to any one of Items 1 to 9, wherein the terpenoid compound is at least one selected from the group consisting of glycyrrhizin (pharmacopoeia name: glycyrrhizic acid) and glycosides thereof, or the group consisting of vitamins E and K and precursors of vitamins E and K.
[0025] Section 11. The metabolite content regulator according to any one of items 1 to 10, wherein the sulfur compound is at least one selected from the group consisting of allicin, precursors and decomposition products of allicin, or the group consisting of isothiocyanate, precursors and decomposition products of isothiocyanate.
[0026] Section 12. Item 12. The metabolite content regulator according to any one of Items 1 to 11, wherein the fatty acid is at least one selected from the group consisting of oleic acid and palmitic acid.
[0027] Section 13. Item 13. The metabolite content regulator according to any one of Items 1 to 12, wherein the target plant is a medicinal plant or a vegetable.
[0028] Section 14. Item 14. The metabolite content regulator according to any one of Items 1 to 13, wherein the medicinal plant is licorice, and the vegetable is arugula, daikon radish, or garlic.
[0029] Section 15. Item 15. A method for regulating a metabolite content in a plant, comprising applying the metabolite content regulator according to any one of Items 1 to 14 to the plant.
[0030] Section 16. Item 15. A method for producing a plant having a regulated metabolite content, comprising applying the metabolite content regulator according to any one of Items 1 to 14 to the plant.
[0031] Section 17. Item 17. The method of claim 16, further comprising harvesting the plant with regulated metabolite content.
[0032] Section 18. Item 18. A plant with a regulated metabolite content, obtainable by the production method according to item 16 or 17.
[0033] Section 19. General formula (1):
[0034] TIFF2024165664000006.tif14170 [In the formula: R1 represents a hydrocarbon group which may be partially replaced by an ester group, a carbonyl group, or an oxygen atom. R2 represents a hydrocarbon group which may be partially replaced by an ester group, a carbonyl group, or an oxygen atom.] and a solvate thereof, and the metabolite content is adjusted as compared with a plant not containing said component. Effect of the Invention
[0035] According to the present disclosure, a metabolic content regulator for a plant can be provided. [Brief description of the drawings]
[0036] [Figure 1] 1 shows the amount of glycyrrhizin in licorice plants and the expression level of glycyrrhizin synthesis-related genes in the control group and the extract-added group, as well as the plant weight of each group, measured in Test Example 1. [Diagram 2] 1 shows the amount of glycyrrhizin in licorice plants and the expression level of glycyrrhizin synthesis-related genes in the control group and the Solidago altissima-derived Compound A-added group, as well as the plant weight of each group, measured in Test Example 3. [Diagram 3] The amounts of glycyrrhizin and expression levels of glycyrrhizin synthesis-related genes in licorice plants measured in Test Example 4 are shown in the control group, the group to which compound B derived from Acanthus nigricans or Acanthus chinensis was added, and the group to which compound C derived from Artemisia capillaris was added, as well as the plant weight of each group. [Figure 4] The expression levels of the glycyrrhizin biosynthesis pathway and glycyrrhizin synthesis-related genes measured in Test Example 5 are shown in the licorice control group and extract-added group, the compound A-derived group added with compound A from Solidago altissima, the compound B-derived groups added with compound B from Acanthus nigricans and Acanthus sinensis, and the compound C-derived group added with compound C from Artemisia capillaris. [Diagram 5]1 shows the metabolite contents of the control group, extract-added group, and Solidago altissima-derived Compound A-added group in Brassicaceae and Liliaceae plants measured in Test Example 6, as well as the plant body weight in each group. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0037] In this specification, the expressions "contain" and "comprise" include the concepts of "contain", "include", "consist essentially of" and "consist only of".
[0038] 1. Metabolite content regulators In one aspect, the present disclosure relates to a plant metabolite content regulator (also referred to as "regulator of the present disclosure" in the present specification) containing at least one selected from the group consisting of a compound represented by general formula (1) (also referred to as "compound of the present disclosure" in the present specification) and a solvate thereof. This will be described below.
[0039] The compounds of the present disclosure have the general formula (1):
[0040] The compound is represented by TIFF2024165664000007.tif14170.
[0041] R1 represents a hydrocarbon group which may be partially substituted with an ester group, a carbonyl group, or an oxygen atom, and R2 represents a hydrocarbon group which may be partially substituted with an ester group, a carbonyl group, or an oxygen atom.
[0042] The hydrocarbon group represented by R1 or R2 is not particularly limited, and examples thereof include chain hydrocarbon groups, cyclic hydrocarbon groups, groups consisting of a combination of a chain hydrocarbon group and a cyclic hydrocarbon group, etc. Among these, chain hydrocarbon groups are preferred, and chain unsaturated hydrocarbon groups are more preferred.
[0043] The number of carbon atoms in the hydrocarbon group represented by R1 or R2 is not particularly limited and is, for example, 1 to 16, preferably 1 to 12, and more preferably 2 to 9.
[0044] When the hydrocarbon group represented by R1 or R2 is a chain unsaturated hydrocarbon group, the number of multiple bonds (double bonds, triple bonds) is, for example, 1 to 5, preferably 1 to 4, and more preferably 1 to 3.
[0045] The hydrocarbon group represented by R1 or R2 may be one in which a part of the hydrocarbon group is replaced with an ester group (-C(=O)-O-, or -OC(=O)-), a carbonyl group (-C(=O)-), or an oxygen atom (-O-). The "part" refers to a divalent group constituting the hydrocarbon group, and is usually a methylene group.
[0046] The hydrocarbon group represented by R1 is preferably a hydrocarbon group partially replaced with an ester group, more preferably a chain hydrocarbon group partially replaced with an ester group, and even more preferably a chain unsaturated hydrocarbon group partially replaced with an ester group.
[0047] More preferably, the compound of the present disclosure has the general formula (2):
[0048] An example of the compound is represented by TIFF2024165664000008.tif29170.
[0049] R2 is the same as above. 11 , R 12 , R 13 R represents a hydrocarbon group which may be partially substituted with an ester group, a carbonyl group or an oxygen atom, or a hydrogen atom. 11 and R 13 may be bonded to form a ring.
[0050] R 11 and R 13 When they are bonded to form a ring, an alicyclic hydrocarbon group is preferred. The number of carbon atoms constituting the ring is preferably 4 to 9, more preferably 5 to 8, and further preferably 6 to 8.
[0051] The compound of the present disclosure is more preferably represented by the general formula (3):
[0052] An example of the compound is represented by TIFF2024165664000009.tif22170.
[0053] R1 and R2 are the same as above. 111 R represents an alkyl group. 111 The alkyl group represented by R is not particularly limited and includes both linear and branched alkyl groups. 111 The number of carbon atoms in the alkyl group represented by R is, for example, 1 to 6, preferably 1 to 4, more preferably 1 to 2, and further preferably 1. 111 Examples of the alkyl group represented by the formula (I) include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a tert-butyl group, a pentyl group, and a hexyl group.
[0054] R 21 R represents a hydrocarbon group which may be partially substituted with an ester group, a carbonyl group, or an oxygen atom (preferably 1 to 2 oxygen atoms, more preferably 1 oxygen atom). 21 The hydrocarbon group represented by the formula (I) is not particularly limited, and examples thereof include chain hydrocarbon groups, cyclic hydrocarbon groups, etc. Among these, preferred are cyclic hydrocarbon groups, and more preferred are alicyclic hydrocarbon groups.
[0055] R 21 The number of carbon atoms in the hydrocarbon group represented by the formula (I) is not particularly limited and is, for example, 2 to 8, more preferably 3 to 7, and further preferably 4 to 5.
[0056] Even more preferably, the compound of the present disclosure has the general formula (4):
[0057] An example of the compound is represented by TIFF2024165664000010.tif22170.
[0058] R 111 is the same as above. 22R represents a hydrocarbon group partially substituted with an ester group (preferably a chain hydrocarbon group, more preferably a chain unsaturated hydrocarbon group), or an alkyl group. 22 The number of carbon atoms in the hydrocarbon group represented by R is not particularly limited, and is, for example, 2 to 12, and preferably 4 to 10. 22 The alkyl group represented by R is not particularly limited and includes both linear and branched alkyl groups. 22 The number of carbon atoms in the alkyl group represented by R is, for example, 1 to 6, preferably 1 to 4, more preferably 1 to 2, and further preferably 1. 22 Examples of the alkyl group represented by the formula (I) include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a tert-butyl group, a pentyl group, and a hexyl group.
[0059] R 22 is preferably a hydrocarbon group partially substituted with an ester group.
[0060] As the compound of the present disclosure, a compound represented by the general formula (5):
[0061] An example of the compound is represented by TIFF2024165664000011.tif28170.
[0062] R 111 is the same as above. 221 represents an unsaturated linear hydrocarbon group.
[0063] R 221 The number of carbon atoms in the chain unsaturated hydrocarbon group represented by the formula: is not particularly limited and is, for example, 2 to 8, more preferably 2 to 6, and further preferably 3 to 5.
[0064] R 221 The number of multiple bonds (double bonds, triple bonds) in the chain unsaturated hydrocarbon group represented by R 221 The multiple bond in the chain unsaturated hydrocarbon group represented by the formula: is preferably a double bond.
[0065] R 221 The chain unsaturated hydrocarbon group represented by R is preferably branched. 221 The chain unsaturated hydrocarbon group represented by the formula (I) is preferably an alkenyl group, more preferably a branched alkenyl group. Examples of the alkenyl group include a vinyl group, an allyl group, a 2-butenyl group, a 3-butenyl group, a 1-methylallyl group, a 2-pentenyl group, and a 2-hexenyl group.
[0066] Specific examples of the compounds of the present disclosure include compounds derived from Solidago altissima, Trifolia gracilis, Trifolia chinensis, and Artemisia capillaris, which are shown in Tables 1 and 2 of the Examples described below.
[0067] The compound of the present disclosure is preferably a plant-derived substance (i.e., a substance contained in a plant). Examples of the plant from which the compound of the present disclosure is derived include, for example, Goldenrod plants such as Solidago altissima; Goldenrod plants such as Scutellaria and Scutellaria; Artemisia such as Artemisia capillaris; Ragweed plants such as Ragweed; Artemisia genus plants such as Erigeron annuus and Fleabane; Artemisia genus plants such as Artemisia gracilis and Artemisia gracilis. Examples of the derived plant include preferably Asteraceae plants, more preferably Goldenrod plants and Goldenrod plants, and even more preferably Solidago altissima, Goldenrod plants, Scutellaria gracilis and Artemisia capillaris.
[0068] The compound of the present disclosure is not particularly limited. Examples of the solvent constituting the solvent medium include water and pharma- ceutically acceptable organic solvents (e.g., ethanol, glycerol, acetic acid, etc.).
[0069] The solvate of the compound of the present disclosure is not particularly limited. Examples of the solvent that constitutes the solvate include water and pharma- ceutically acceptable organic solvents (e.g., ethanol, glycerol, acetic acid, etc.).
[0070] The compounds of the present disclosure can be prepared in a variety of ways.
[0071] The compound of the present disclosure can be, for example, an extract obtained by extraction from a plant, or a compound obtained by separation and / or purification from the extract.
[0072] The part of the plant used for extraction is not particularly limited, and examples thereof include roots, stems, leaves, flowers, seeds, etc. The extraction solvent is not particularly limited. Examples of the extraction solvent include water; alcohols such as methanol, ethanol, propanol, butanol, etc.; alkyl acetates such as methyl acetate, ethyl acetate, propyl acetate, butyl acetate, etc.; and supercritical carbon dioxide. The extraction solvent may be one type alone or a combination of two or more types. The temperature of the solvent during extraction is not particularly limited, but is preferably 20 to 25°C. The extraction time varies depending on the extraction method, solvent, temperature, etc., and is not particularly limited.
[0073] The compounds of the present disclosure can be separated from the extract and further purified by conventional separation means, such as distillation, recrystallization, column chromatography, ion exchange chromatography, gel chromatography, affinity chromatography, preparative thin layer chromatography, solvent extraction, and the like.
[0074] As the compounds of the present disclosure, commercially available compounds can be used, and compounds synthesized using commercially available compounds as starting materials can also be used.
[0075] The compounds and solvates thereof disclosed herein have a metabolic content regulating activity in plants. Therefore, at least one selected from the group consisting of the compounds and solvates thereof disclosed herein can be used as an active ingredient of a metabolic content regulator in plants (regulator of the present disclosure).
[0076] The regulator of the present disclosure is used to regulate the metabolite content in plants. "Regulating the metabolite content" refers to changing the metabolite content, and includes both improving the metabolite content and decreasing the metabolite content. In a preferred embodiment of the present disclosure, the regulator of the present disclosure is a metabolite content improving agent.
[0077] The target plants of the regulator of the present disclosure are limited to medicinal plants and the following plants. Crops; corn (horse-tooth, hard, soft, burst, glutinous, sweet, field corn), rice (long, short, medium, japonica, tropical japonica, indica, javanica, paddy, upland, floating, direct-seeded, transplanted, glutinous), wheat (bread wheat (hard, soft, medium, red, white), durum, spelt, club, each winter and spring type), barley (two-rowed barley (= beer barley), six-rowed barley, naked barley, waxy barley, each winter and spring type), rye (winter rye type, spring rye type), triticale (winter triticale type, spring triticale type), oats (winter oat type) , spring oat type), sorghum, cotton (upland type, pima type), soybean (fully ripened seed harvested variety, edamame variety, green harvested variety, indeterminate, determinate, semi-determinate types), groundnut, Japanese bean, lima bean, adzuki bean, cowpea, mung bean, uradome, scarlet bean, bamboo bean, moss bean, tepary bean, broad bean, pea, chickpea, lentil, lupin, pigeon pea, alfalfa, buckwheat, sugar beet (sugar processing, feed, root vegetable, leafy vegetable, fuel), rapeseed (winter rapeseed type, spring rapeseed type), canola (winter canola type, spring canola type), sunflower (oil extraction, food, ornamental), sugarcane, tobacco, tea plant, mulberry, etc. Vegetables: Solanaceae vegetables (eggplant, tomato, green pepper, chilli, bell pepper, potato, etc.), Cucurbitaceae vegetables (cucumber, pumpkin, zucchini, watermelon, melon, squash, etc.), Cruciferae vegetables (radish, turnip, horseradish, kohlrabi, Chinese cabbage, cabbage, mustard, broccoli, cauliflower, etc.), Asteraceae vegetables (burdock, chrysanthemum, artichoke, lettuce, etc.), Liliaceae vegetables (leeks, onions, garlic, asparagus, etc.), Apiaceae vegetables (carrots, parsley, celery, parsley, etc.), Chenopodiaceae vegetables (spinach, Swiss chard, etc.), Lamiaceae vegetables (perilla, mint, basil, lavender, etc.), strawberries, sweet potatoes, Chinese yams, taro, etc. Fruit trees; pome fruits (apples, European pears, Japanese pears, Chinese pears, quince, quince, etc.), stone fruits (peaches, plums, nectarines, plums, cherries, apricots, prunes, etc.), citrus fruits (Satsuma mandarins, oranges, lemons, limes, grapefruits, etc.), nuts (chestnuts, walnuts, hazels, almonds, pistachios, cashew nuts, macadamia nuts, etc.), berries (blueberries, cranberries, blackberries, raspberries, etc.), grapes, persimmons, figs, olives, loquats, bananas, coffee, dates, coconuts, etc. Ornamental plants; flowering trees, street trees (ash, birch, dogwood, eucalyptus, ginkgo, lilac, maple, oak, poplar, redbud, liquidamum, plane tree, zelkova, arborvitae, fir, hemlock, juniper, pine, spruce, yew), flowers, ornamental plants, turf grasses. The above-mentioned plants are not limited as long as they are varieties that are commonly cultivated.
[0078] Among these, the target plants of the regulator of the present disclosure preferably include legume plants (e.g., licorice, etc.), Brassicaceae plants (e.g., radish and arugula, etc.), and liliaceae plants (e.g., garlic, etc.), and more preferably include legume plants. Among legume plants, particularly preferred are Licorice plants. Examples of Licorice plants include G. echinata, G. glabra, G. lepidota, G. uralensis, G. inflata, and the like.
[0079] In one embodiment, the target plant of the regulator of the present disclosure is preferably a plant that is used for the utilization of metabolites, such as a medicinal plant or a vegetable. A medicinal plant means a plant of which at least a part is used for medicinal purposes. Examples of medicines include crude drugs (unrefined drugs, medicinal herbs), herbal medicines, and folk medicines, and also include foods that are not classified as medicines under the Pharmaceutical Affairs Law. A vegetable means a herbaceous plant that is harvested within one year after planting. Examples of parts of medicinal plants that are used for medicinal purposes or parts of vegetables that are used include the whole plant, stems and leaves, flowers, buds, seeds, fruits, pericarp, roots, rhizomes, xylem, bark, and plant parts containing two or more of these.
[0080] Medicinal plants include: ginseng, angelica, lily of the valley, inchinko, fennel, corydalis, astragalus, scutellaria, phellodendron bark, coptis, onji, chinese ginseng, kashun, kasseki, kalochon, calonin, liquorice, bellflower, chrysanthemum, pheasant, kyokatsu, apricot kernel, sophora, cinnamon, cinnamon bark, kouuka, red ginseng, magnolia, and kobushi. Ubei, Magnolia, Bark, Goshitsu, Goshuyu, Goboshi, Sesame, Gomishi, Saiko, Saishin, Hawthorn, Sanshishi, Cornus, Japanese pepper, Sanshounin, Dioscorea, Japanese laurel, Lithospermum, Lithospermum, Chinese ephedra, Peony, Chinese peony, Chinese laurel, Japanese laurel, Chinese laurel, Japanese anemone, Japanese anemone, Chinese ginger, Japanese anemone, Japanese laurel, Chinese ginger, Japanese anemone, Japanese anemone, Japanese anemone, Kotsu, Senna, Sophora Root, Sophora Root, Soboku, Soybean, Rhubarb, Chinese Cabbage, Chinese Carrot, Timo, Tea, Clove, Buttercup, Chinese Pepper, Chinese Chimney, Chinese Tenmangu, Chinese Bead, Japanese Pepper, Japanese Angelica, Japanese Sprout, Japanese Sprout, Ipecac, Eucommia, Dokkatsu, Carrot, Bean, Fritillaria, Bacteria, Moth, Bacteroides Examples include alder, mint, sea laurel, Chinese angelica, white gourd, white angelica, white atractylodes, loquat, areca nut, bupleurum, bush clover, dung bean, bowi, sedge, boxwood, moutan pea, borage, ephedra, machina, scutellaria, bamboo shoots, mock orange, coix seed, longan berry, scutellaria, scutellaria, ryegrass, forsythia, lotus fruit, and wakyoukatsu.
[0081] Metabolites include primary metabolites and secondary metabolites. Primary metabolites are directly involved in the life of plants, such as cell growth, development, and reproduction, while secondary metabolites are not directly involved in life, but instead usually have functions such as protecting themselves from external stress (ultraviolet rays, etc.) and external enemies (pathogens, etc.). The synthesis of fatty acids, which are the main raw materials of biomembranes, is regulated to protect themselves from external stress, just like secondary metabolites. Metabolites include terpenoid compounds, flavonoid compounds, alkaloid compounds, terpene compounds, sulfur compounds, phenolic compounds, derivatives thereof, glycosides thereof, and fatty acids. Among these, terpenoid compounds, sulfur compounds, and glycosides thereof, and fatty acids are preferred.
[0082] Examples of sugars constituting glycosides include glucose, arabinose, pyranose, raffinose, rutinose, apiose, rhamnose, rutinose, primeverose, gentiobiose, digitoxose, galactose, xylose, and the like, and further include sugars formed by linking multiple of these.
[0083] Examples of terpenoid compounds and their glycosides include glycyrrhizin, farnesol, glycyrrhetinic acid, picrotoxin, cantharidin, grayanotoxin, phorbol, perillaldehyde, terpene alkaloids, pinene, 10-deacetylbaccatin, linalyl acetate, geranic acid, halomone, citronellal, lycopene, rose oxide, geranyl acetate, anisatin, linalool, cryptoxanthin, glycyrrhetinic acid, cineole, thujone, guaiazulene, geraniol, abscisic acid, sesquiterpene lactone, cucurbitacin, cymene, squalene, nootkatone, borneol, nerol, angelic acid, ionone, carvone, absinthin, thioterpineol, bisabolol, dimethylallyl diphosphate, and nepetalactone. , azadirachtin, phellandrene, abietic acid, strigolactone, menthone, cuminaldehyde, prostratin, citral, artemisinin, 12-O-tetradecanoylphorbol 13-acetate, trichothecene, azulene, carveol, huperzine A, ginkgolides, lactucopicrin, coriamyrtin, limonene, phytol, gibberellic acid, crocin, menthane, thymol, lanosterol, saponin, ascaridole, isopentenyl diphosphate, indomethacin farnesyl, longifolene, β-cryptoxanthin, iridoids, tiglic acid, 3-methylbutanoic acid, myrcene, verbenone, taxane, terpineol, fucoxanthin, parthenolide, geranylgeranyl pyrophosphate, santalol, etc.
[0084] The sulfur compounds include allicin, alliin, ajoene, isothiocyanates, etc., and their precursors and decomposition products.
[0085] Examples of fatty acids include oleic acid, linoleic acid, linolenic acid, stearic acid, and palmitic acid.
[0086] The regulator of the present disclosure may consist of only the active ingredient, but may contain various other ingredients in addition to the active ingredient depending on the dosage form, application mode, etc. described below. The content ratio of the active ingredient (dry weight) in the regulator of the present disclosure can be appropriately determined depending on the dosage form, application mode, etc. described below, and can be, for example, in the range of 0.0001 to 100 mass%. The upper limit of the content ratio is, for example, 99 mass%, 98 mass%, 97 mass%, 95 mass%, 90 mass%, 80 mass%, 70 mass%, or 60 mass%. The lower limit of the content is, for example, 0.001 mass%, 0.01 mass%, 0.1 mass%, 1 mass%, 2 mass%, 3 mass%, 5 mass%, 10 mass%, 20 mass%, 30 mass%, 40 mass%, or 50 mass%.
[0087] Examples of other components include carriers, adhesives, dispersants, and auxiliary agents. Examples of carriers include solid carriers such as talc, bentonite, clay, kaolin, diatomaceous earth, white carbon, vermiculite, and silica sand; and liquid carriers such as water-soluble polymer compounds (polyvinyl alcohol, polyvinylpyrrolidone, polyacrylic acid, and the like), water, vegetable oil, and liquid animal oil. Examples of adhesives include casein, gelatin, gum arabic, and alginic acid. Examples of dispersants include alcohol sulfates and polyoxyethylene glycol ether. Examples of auxiliary agents include carboxymethylcellulose, starch, and lactose. The above carriers, adhesives, dispersants, and auxiliary agents can be used alone or in appropriate combination according to their respective purposes.
[0088] The formulation of the regulator of the present disclosure is not particularly limited as long as it is an agriculturally acceptable formulation. For example, granules such as granules, 1 kilo granules, 500 grams granules, 250 grams granules, jumbo formulations, etc.; powders such as dusts, DL dusts, FD dusts, etc.; powders such as dusts, fine granules F, fine granules F, etc.; powders; hydrated powders, flowable sol SC, granular water dispersible powders, dry flowable powders, etc.; hydrated powders such as water soluble powders, water soluble granules, etc.; emulsions such as emulsions, EW formulations, etc.; liquids such as liquids, EW formulations, etc.; oils such as oils, surf formulations, etc.; aerosols; pastes; microcapsules; packs, etc.
[0089] Regulators of the present disclosure can be applied to plants to regulate the metabolite content of the plants.
[0090] The application is not particularly limited as long as the active ingredient can contact the plant cells. For example, the application is to a medium (e.g., soil, etc.). In this case, the concentration of the active ingredient in the medium is, for example, 0.02 to 500 ppm, preferably 0.1 to 200 ppm, more preferably 0.3 to 100 ppm, even more preferably 1 to 50 ppm, even more preferably 3 to 30 ppm, and particularly preferably 5 to 20 ppm.
[0091] Examples of application modes include spraying, dripping, coating, mixing or dissolving in the plant growth environment (soil, water, solid medium, liquid medium, etc.), etc. More specifically, examples include adding to a hydroponic solution, spraying on the soil surface, mixing with fertilizer, etc.
[0092] 2. Regulation method, manufacturing method, plant In one aspect, the present disclosure relates to a method for regulating the metabolite content of a plant, comprising applying a regulator of the present disclosure to the plant. In one aspect, the present disclosure relates to a method for producing a plant having a regulated metabolite content, comprising applying a regulator of the present disclosure to the plant. These methods may be collectively referred to as the "methods of the present disclosure."
[0093] The method of the present disclosure regulates the metabolite content of plants.In one embodiment, the content of at least one kind of metabolite of the plant obtained by applying the regulator of the present disclosure is improved, for example, by 1.1 times or more, 1.2 times or more, 1.3 times or more, 1.5 times or more, 1.7 times or more, 2.0 times or more, 2.2 times or more, or 2.5 times or more, compared with the plant obtained under the same conditions except that the regulator of the present disclosure is not applied.
[0094] The method of the present disclosure preferably further comprises harvesting the plant with the regulated metabolite content. The harvesting is not particularly limited as long as it is a step of separating the plant or a part thereof from the soil or medium and making it mobile (e.g., for distribution). The harvesting step may include a step of washing, processing, etc. the plant, as necessary.
[0095] In one aspect, the present disclosure relates to a plant with a regulated metabolite content that can be obtained by the method of the present disclosure. The plant usually contains an active ingredient. Therefore, in one aspect, the present disclosure also relates to a plant that contains an active ingredient and has a regulated metabolite content compared to a plant that does not contain the active ingredient. In these aspects, the degree of regulation of the metabolite is as described above.
[0096] The metabolite content of a plant can be measured according to or in accordance with a known method depending on the type of metabolite of interest. For example, the content can be measured according to or in accordance with the method described in the Examples below. EXAMPLES
[0097] The present invention will be described in detail below based on examples, but the present invention is not limited to these examples.
[0098] Test Example 1 An extract was extracted from Solidago altissima, and an activity test was conducted to evaluate the metabolite content regulating activity of the obtained extract. The activity evaluation was performed using the metabolite glycyrrhizin and the expression of the glycyrrhizin synthesis-related gene (CYP72A154) as indicators. The specific method is as follows.
[0099] <Test Example 1-1. Glycyrrhiza growth conditions> Licorice (Glycyrrhiza uralensis) seeds were surface-sterilized with 10% sodium hypochlorite solution for 5 minutes and washed three times with sterile water. The sterilized seeds were sown on MS medium (FUJIFILM Wako) containing 0.5% sucrose, 2.00 mg / L glycine, 100 mg / L myo-inositol, 0.50 mg / L nicotinic acid, 0.50 mg / L pyridoxine hydrochloride, 0.10 mg / L thiamine hydrochloride, and 0.8% agar, pH 5.7. The germinated seeds were transferred to MS medium containing 3% sucrose, 2.00 mg / L glycine, 100 mg / L myo-inositol, 0.50 mg / L nicotinic acid, 0.50 mg / L pyridoxine hydrochloride, 0.10 mg / L thiamine hydrochloride, and 0.8% agar, pH 5.7. Germination and cultivation were carried out at a temperature of approximately 25°C and a light / dark cycle of 16 / 8 hours.
[0100] <Test Example 1-2. Extraction of Solidago altissima extract> Extracts were extracted from the rhizomes and roots of Solidago altissima. Specifically, the procedure was as follows. Specifically, the underground parts of Solidago altissima were dried in the sun for 2-3 days. The obtained underground parts were extracted overnight with 2.5 times the amount of hexane at room temperature. Extraction was performed three times, and the obtained extracts were combined and concentrated under reduced pressure to obtain a hexane extract. The component concentrations were measured by liquid chromatography.
[0101] <Test Example 1-3. Activity test> After sowing and culturing for one week, the licorice plants were transplanted onto MS medium containing Solidago altissima extract at a concentration of 10 ppm (extract-added group) or onto control MS medium without the extract (control group), and cultured for three weeks.
[0102] After cultivation, the licorice was divided into above-ground parts and roots, weighed, frozen in liquid nitrogen, and crushed. 2 mL of a mixed solution of MeOH-CHCl3-H2O (2.5:1:1) was added per 160 mg of plant body weight, and the mixture was centrifuged to obtain the supernatant. Next, 1 mL of a mixed solution of MeOH-CHCl3 (1:1) was added, and the mixture was centrifuged to obtain the supernatant. 0.5 mL of water was added to the combined solution of the two supernatants, mixed, and the amount of glycyrrhizin in the aqueous layer was analyzed. The analytical equipment and analytical conditions are as follows. Instrument: Shimadzu LC-IT-TOF mass spectrometer equipped with an ESI interface. ESI parameters: voltage, -3.5 kV (negative ion mode); capillary temperature, 200 °C; nebulizer gas flow rate, 1.5 L / min. ·MS conditions: Measurement range m / z 700 to 1000. Ion accumulation time 100 ms. HPLC conditions: Column A: Waters Atlantis T3 column (2.1 mm id × 150 mm, 5 μm). Column temperature: 40°C. Mobile phase: (A) 5 mM ammonium acetate solution (B) acetonitrile. Gradient condition: 0-30 min, linear gradient from 10 to 100% B, and 30-40 min, isocratic at 100% B. Flow rate: 0.2 mL / min.
[0103] After the cultivation, the licorice was divided into aboveground parts and roots, weighed, frozen in liquid nitrogen, and crushed. 1 mL of isogen II (Nippon Gene Co., Ltd., 311-07361) was added per 20 mg of plant body weight, and the mixture was stirred vigorously. 400 μL of water was added and stirred vigorously, then left to stand for 10 minutes, and then centrifuged to obtain 1 mL of supernatant. 1 mL of 100% isopropanol solution was added to the supernatant, the tube was tilted to stir, left to stand for 10 minutes, and then centrifuged to obtain an RNA pellet. The pellet was washed with 75% ethanol solution and dissolved in water. 200 ng of RNA dissolved in water was weighed, and DNase treatment was performed according to the protocol for RQ1 RNase-Free DNase (Promega, M6101), and cDNA synthesis was performed according to the protocol for LunaScript RT SuperMix Kit (New England BioLabs, E3010L). The synthesized cDNA was diluted 10-fold, and gene amount was quantified by RT-PCR according to the protocol for Luna Universal qPCR Master Mix (New England BioLabs, M3003E) to analyze gene expression. · RT-PCR equipment: Applied Bioscience Step one Plus (#4376592). RT-PCR conditions: 1 cycle of 95℃ for 60 seconds, 40 cycles of 95℃ for 15 seconds and 60℃ for 30 seconds, melting curve measurement Analysis method: The gene amounts (Ct values) of the housekeeping gene ACT7 and the glycyrrhizin synthesis-related gene CYP72A154 were measured. The expression levels of the glycyrrhizin synthesis gene were calculated using the ddCt method {2^-(glycyrrhizin synthesis gene amount - housekeeping gene amount)}.
[0104] <Result> The expression levels of glycyrrhizin and glycyrrhizin synthesis-related gene (CYP72A154) in the control group and the extract-added group, as well as the plant weight of each group, are shown in Figure 1. The amount of glycyrrhizin in the plant and the expression of glycyrrhizin synthesis-related gene (CYP72A154) were significantly increased in the extract-added group ( *p < 0.05), but no significant difference was observed in plant weight change.
[0105] Test Example 2 The components in Solidago altissima extract (Test Example 1-2) were analyzed by HPLC. Specifically, 1 mg of Solidago altissima hexane extract was accurately weighed and dissolved in 1 mL of methanol. The solution was diluted 2-fold (0.5 mg / mL solution), filtered, and used as a sample. Similarly, 0.005, 0.01, and 0.05 mg / mL standard solutions were prepared for the isolated cis-dehydromatricaria ester, (2Z, 8Z)-10-angeloyloxy-matricaria ester, and (2Z, 8Z)-10-tigloyloxy-matricaria ester. These were subjected to HPLC analysis, and the polyacetylene content in the hexane extract was calculated from the obtained peak area. The measurement conditions are shown below. Some of the results are shown in Table 1. Detector: Photodiode array detector SPD-M20A Measurement conditions: Column A: Waters Atlantis T3 column (2.1 mm id × 150 mm, 5 μm). Column temperature: 40°C. Mobile phase: (A) 5 mM ammonium acetate solution (B) acetonitrile. Gradient condition: 0-30 min, linear gradient from 10 to 100% B, and 30-40 min, isocratic at 100% B. Flow rate: 0.2 mL / min. Wavelength: 254 nm.
[0106] [Table 1] As shown in Table 1, Solidago altissima extract contained several compounds with a structure in which two ethynylene groups were lined up.
[0107] Test Example 3 An activity test was conducted to evaluate the metabolite content regulating activity of one of the compounds identified in Test Example 2 (Compound A: (2Z,8Z)-10-angeloyloxy-matricaria ester, the second compound from the top in Table 1). Activity evaluation was performed using the metabolite glycyrrhizin and the expression of the glycyrrhizin synthesis-related gene (CYP72A154) as indicators. The specific method is as follows.
[0108] <Test Example 3-1. Glycyrrhiza growth conditions> Licorice (Glycyrrhiza uralensis) seeds were surface-sterilized with 10% sodium hypochlorite solution for 5 minutes and washed three times with sterile water. The sterilized seeds were sown on MS medium (FUJIFILM Wako) containing 0.5% sucrose, 2.00 mg / L glycine, 100 mg / L myo-inositol, 0.50 mg / L nicotinic acid, 0.50 mg / L pyridoxine hydrochloride, 0.10 mg / L thiamine hydrochloride, and 0.8% agar, pH 5.7. The germinated seeds were transferred to MS medium containing 3% sucrose, 2.00 mg / L glycine, 100 mg / L myo-inositol, 0.50 mg / L nicotinic acid, 0.50 mg / L pyridoxine hydrochloride, 0.10 mg / L thiamine hydrochloride, and 0.8% agar, pH 5.7. Germination and cultivation were carried out at a temperature of approximately 25°C and a light / dark cycle of 16 / 8 hours.
[0109] <Test Example 3-2. Purification of Compound A> Compound A was purified from Solidago altissima root. Specifically, the purification was carried out as follows. As in Test Example 1, a hexane extract was obtained, and then the target compound was separated and obtained by liquid chromatography.
[0110] A hexane extract (10.9 g) obtained from the underground parts of Solidago altissima (435 g) was subjected to silica gel column chromatography (solvent: chloroform) and fractionated into nine fractions (Fr. 1 to Fr. 9). Fr. 2 (665 mg) was subjected to medium pressure silica gel chromatography (solvent: hexane:ethyl acetate=5:1) and separated into four fractions (Fr. 2-1 to 2-4). The obtained Fr. 2-3 was concentrated and dried under reduced pressure to obtain cis-dehydromatricaria ester (89 mg).
[0111] Fr.2-2 (50 mg) was subjected to preparative thin-layer chromatography (solvent: hexane:ethyl acetate=5:1) and separated into four fractions (Fr.2-2-1 to 2-2-4). The obtained Fr.2-2-2 was concentrated to dryness under reduced pressure to give trans-dehydromatricaria ester (11 mg).
[0112] Fr.3 (653 mg) was subjected to medium pressure silica gel chromatography (solvent: hexane:ethyl acetate=5:1) and separated into 5 fractions (Fr.3-1 to 3-5). Fr.3-3 (328 mg) was subjected to ODS column chromatography (solvent: methanol:water=85:15) and separated into 3 fractions (Fr.3-3-1 to 3-3-3). The obtained Fr.3-3-2 was concentrated under reduced pressure and dried to obtain compound A (2Z,8Z)-10-angeloyloxy-matricaria ester (299 mg).
[0113] A combined fraction of 296 mg, consisting of Fr.4, Fr.5, and Fr.3-4, was subjected to ODS column chromatography (solvent: methanol: water = 85:15) and separated into seven fractions (Fr.4-1 to 4-7). A combined fraction of 72 mg, consisting of Fr.4-2 and Fr.3-3-1, was subjected to preparative reversed-phase high-performance liquid chromatography (solvent: acetonitrile: water = 65:35) and separated into four fractions (Fr.4-2-1 to 4-2-4). The obtained Fr. 4-2-1 to Fr. 4-2-3 were concentrated under reduced pressure and dried to give (2Z, 8Z)-10-methacryloyloxy-matricaria ester (2.2 mg), (2Z, 8Z)-10-isobutyryloxy-matricaria ester (0.8 mg), and (2Z, 8Z)-10-tigloyloxy-matricaria ester (33.1 mg), respectively.
[0114] <Test Example 3-3. Activity test> Licorice plants cultured for one week after sowing were transplanted onto MS medium containing compound A at a concentration of 10 ppm (compound-added group) and onto control MS medium containing no compound (control group), and cultured for three weeks.
[0115] After cultivation, the licorice was divided into above-ground parts and roots, weighed, frozen in liquid nitrogen, and crushed. 2 mL of a mixed solution of MeOH-CHCl3-H2O (2.5:1:1) was added per 160 mg of plant body weight, and the mixture was centrifuged to obtain the supernatant. Next, 1 mL of a mixed solution of MeOH-CHCl3 (1:1) was added, and the mixture was centrifuged to obtain the supernatant. 0.5 mL of water was added to the combined solution of the two supernatants, mixed, and the amount of glycyrrhizin in the aqueous layer was analyzed. The analytical equipment and analytical conditions are as follows. Instrument: Shimadzu LC-IT-TOF mass spectrometer equipped with an ESI interface. ESI parameters: voltage, -3.5 kV (negative ion mode); capillary temperature, 200 °C; nebulizer gas flow rate, 1.5 L / min. ·MS conditions: Measurement range m / z 700 to 1000. Ion accumulation time 100 ms. HPLC conditions: Column A: Waters Atlantis T3 column (2.1 mm id × 150 mm, 5 μm). Column temperature: 40°C. Mobile phase: (A) 5 mM ammonium acetate solution (B) acetonitrile. Gradient condition: 0-30 min, linear gradient from 10 to 100% B, and 30-40 min, isocratic at 100% B. Flow rate: 0.2 mL / min.
[0116] After the cultivation, the licorice was divided into aboveground parts and roots, weighed, frozen in liquid nitrogen, and crushed. 1 mL of isogen II (Nippon Gene Co., Ltd., 311-07361) was added per 20 mg of plant body weight, and the mixture was stirred vigorously. 400 μL of water was added and stirred vigorously, then left to stand for 10 minutes, and then centrifuged to obtain 1 mL of supernatant. 1 mL of 100% isopropanol solution was added to the supernatant, the tube was tilted to stir, left to stand for 10 minutes, and then centrifuged to obtain an RNA pellet. The pellet was washed with 75% ethanol solution and dissolved in water. 200 ng of RNA dissolved in water was weighed, and DNase treatment was performed according to the protocol for RQ1 RNase-Free DNase (Promega, M6101), and cDNA synthesis was performed according to the protocol for LunaScript RT SuperMix Kit (New England BioLabs, E3010L). The synthesized cDNA was diluted 10-fold, and gene amount was quantified by RT-PCR according to the protocol for Luna Universal qPCR Master Mix (New England BioLabs, M3003E) to analyze gene expression. · RT-PCR equipment: Applied Bioscience Step one Plus (#4376592). RT-PCR conditions: 1 cycle of 95℃ for 60 seconds, 40 cycles of 95℃ for 15 seconds and 60℃ for 30 seconds, melting curve measurement Analysis method: The gene amounts (Ct values) of the housekeeping gene ACT7 and the glycyrrhizin synthesis-related gene CYP72A154 were measured. The expression levels of the glycyrrhizin synthesis gene were calculated using the ddCt method {2^-(glycyrrhizin synthesis gene amount - housekeeping gene amount)}.
[0117] <Result> The expression levels of glycyrrhizin and glycyrrhizin synthesis-related genes (CYP72A154) in the control group and the Solidago altissima-derived compound A-added group, as well as the plant weight of each group, are shown in Figure 2. The amount of glycyrrhizin in the plant and the expression of glycyrrhizin synthesis-related genes (CYP72A154) in the Solidago altissima-derived compound A-added group were significantly increased ( * p < 0.05), but no significant difference was observed in plant weight change.
[0118] Test Example 4 An activity test was carried out to evaluate the metabolite content regulating activity of compound B derived from Acanthus nigricans and Acanthus sinensis and compound C derived from Artemisia capillaris, as shown in Table 2 below. The activity evaluation was carried out using the metabolite glycyrrhizin and the expression of the glycyrrhizin synthesis-related gene (CYP72A154) as indicators. The specific method is as follows.
[0119] [Table 2]
[0120] <Test Example 4-1. Glycyrrhiza growth conditions> Licorice (Glycyrrhiza uralensis) seeds were surface-sterilized with 10% sodium hypochlorite solution for 5 minutes three times and washed with sterile water three times. The sterilized seeds were sown on MS medium (FUJIFILM Wako) containing 0.5% sucrose, 2.00 mg / L glycine, 100 mg / L myo-inositol, 0.50 mg / L nicotinic acid, 0.50 mg / L pyridoxine hydrochloride, 0.10 mg / L thiamine hydrochloride, 0.8% agar, and adjusted to pH 5.7. The germinated seeds were transferred to MS medium containing 3% sucrose, 2.00 mg / L glycine, 100 mg / L myo-inositol, 0.50 mg / L nicotinic acid, 0.50 mg / L pyridoxine hydrochloride, 0.10 mg / L thiamine hydrochloride, 0.8% agar, and pH 5.7. Germination and cultivation were carried out at a temperature of approximately 25°C and under a 16 / 8 hour light / dark cycle.
[0121] <Test Example 4-2. Activity test> Licorice plants cultured for one week after sowing were then transferred to MS medium containing compounds with a diacetylene structure at a concentration of 10 ppm (compound B / C addition group) or to control MS medium without the compounds (control group) and cultured for three weeks.
[0122] After cultivation, the licorice was divided into above-ground parts and roots, weighed, frozen in liquid nitrogen, and crushed. 1 mL of EtOH-H2O (1:1) mixed solution was added per 100 mg of plant body weight, and the mixture was centrifuged to obtain the supernatant. Next, 1 mL of EtOH-H2O (1:1) mixed solution was added, and the mixture was centrifuged to obtain the supernatant. The combined solution of the two supernatants was passed through a 450 nm filter, and the amount of glycyrrhizin in the solution was analyzed. The analytical equipment and analytical conditions are as follows: Equipment: Waters Xevo G2-XS QTof MS conditions: Capillary voltage, 2.6 kV (negative ion mode); source temperature, 150℃; desolvation gas temperature, 0℃; desolvation gas flow rate, 800 L / hr; m / z range, 400 to 2000. HPLC conditions: Column A: Waters HSS C18 column (2.1 mm id × 150 mm, 1.8 μm). Column temperature: 40°C. Mobile phase: (A) 5 mM ammonium acetate solution (B) acetonitrile. Gradient condition: (B) 25%→(8 min)→49%→(1 min)→100%(5 min). Flow rate: 0.2 mL / min.
[0123] After the cultivation, the licorice was divided into aboveground parts and roots, weighed, frozen in liquid nitrogen, and crushed. 1 mL of isogen II (Nippon Gene Co., Ltd., 311-07361) was added per 20 mg of plant body weight, and the mixture was stirred vigorously. 400 μL of water was added and stirred vigorously, then left to stand for 10 minutes, and then centrifuged to obtain 1 mL of supernatant. 1 mL of 100% isopropanol solution was added to the supernatant, the tube was tilted to stir, left to stand for 10 minutes, and then centrifuged to obtain an RNA pellet. The pellet was washed with 75% ethanol solution and dissolved in water. 200 ng of RNA dissolved in water was weighed, and DNase treatment was performed according to the protocol for RQ1 RNase-Free DNase (Promega, M6101), and cDNA synthesis was performed according to the protocol for LunaScript RT SuperMix Kit (New England BioLabs, E3010L). The synthesized cDNA was diluted 10-fold, and gene amount was quantified by RT-PCR according to the protocol for Luna Universal qPCR Master Mix (New England BioLabs, M3003E) to analyze gene expression. · RT-PCR equipment: Applied Bioscience Step one Plus (#4376592). RT-PCR conditions: 1 cycle of 95℃ for 60 seconds, 40 cycles of 95℃ for 15 seconds and 60℃ for 30 seconds, melting curve measurement Analysis method: The gene amounts (Ct values) of the housekeeping gene ACT7 and the glycyrrhizin synthesis-related gene CYP72A154 were measured. The expression levels of the glycyrrhizin synthesis gene were calculated using the ddCt method {2^-(glycyrrhizin synthesis gene amount - housekeeping gene amount)}.
[0124] <Result> The expression levels of glycyrrhizin and glycyrrhizin synthesis-related genes (CYP72A154) in the control group and the group to which a compound with a diacetylene structure was added, as well as the plant weight of each group, are shown in Figure 3. In the group to which compound B derived from Hosobaokera and Shinaokera was added, the amount of glycyrrhizin in the plants increased, and the expression of glycyrrhizin synthesis-related genes (CYP72A154) was significantly increased ( *** p< 0.001), but no significant difference was observed in the change in plant weight. In addition, the amount of glycyrrhizin in the plants increased in the group to which compound C derived from Artemisia capillaris was added, and the expression of the glycyrrhizin synthesis-related gene (CYP72A154) was significantly increased ( * p < 0.05), but no significant difference was observed in plant weight change.
[0125] Test Example 5 Activity tests were carried out to evaluate the mechanism of metabolite content regulating activity of the extract used in Test Example 1, compound A derived from Solidago altissima used in Test Example 3, compound B derived from Acanthus nigricans and Acanthus chinensis used in Test Example 4, and compound C derived from Artemisia capillaris. Activity evaluation was carried out using the gene expression level of the glycyrrhizin synthesis-related gene group as an index. The specific method is as follows.
[0126] <Test Example 5-1. Licorice growth conditions> Licorice (Glycyrrhiza uralensis) seeds were surface-sterilized with 10% sodium hypochlorite solution for 5 minutes three times and washed with sterile water three times. The sterilized seeds were sown on MS medium (FUJIFILM Wako) containing 0.5% sucrose, 2.00 mg / L glycine, 100 mg / L myo-inositol, 0.50 mg / L nicotinic acid, 0.50 mg / L pyridoxine hydrochloride, 0.10 mg / L thiamine hydrochloride, 0.8% agar, and adjusted to pH 5.7. The germinated seeds were transferred to MS medium containing 3% sucrose, 2.00 mg / L glycine, 100 mg / L myo-inositol, 0.50 mg / L nicotinic acid, 0.50 mg / L pyridoxine hydrochloride, 0.10 mg / L thiamine hydrochloride, 0.8% agar, and pH 5.7. Germination and cultivation were carried out at a temperature of approximately 25°C and under a 16 / 8 hour light / dark cycle.
[0127] <Test Example 5-2. Activity test> Licorice plants cultured for one week after sowing were then transplanted onto MS medium (extract / compound-added group) to which the extracts and compound A derived from Solidago altissima, compound B derived from Trifolium gracilis and Trifolium chinense, and compound C derived from Artemisia capillaris were added at a concentration of 10 ppm, or onto control MS medium (control group) to which the extracts and compound A were not added, and cultured for three weeks.
[0128] After the cultivation, the licorice was divided into aboveground parts and roots, weighed, frozen in liquid nitrogen, and crushed. 1 mL of isogen II (Nippon Gene Co., Ltd., 311-07361) was added per 20 mg of plant body weight, and the mixture was stirred vigorously. 400 μL of water was added and stirred vigorously, then left to stand for 10 minutes, and then centrifuged to obtain 1 mL of supernatant. 1 mL of 100% isopropanol solution was added to the supernatant, the tube was tilted to stir, left to stand for 10 minutes, and then centrifuged to obtain an RNA pellet. The pellet was washed with 75% ethanol solution and dissolved in water. 200 ng of RNA dissolved in water was weighed, and DNase treatment was performed according to the protocol for RQ1 RNase-Free DNase (Promega, M6101), and cDNA synthesis was performed according to the protocol for LunaScript RT SuperMix Kit (New England BioLabs, E3010L). The synthesized cDNA was diluted 10-fold, and gene amount was quantified by RT-PCR according to the protocol for Luna Universal qPCR Master Mix (New England BioLabs, M3003E) to analyze gene expression. · RT-PCR equipment: Applied Bioscience Step one Plus (#4376592). RT-PCR conditions: 1 cycle of 95℃ for 60 seconds, 40 cycles of 95℃ for 15 seconds and 60℃ for 30 seconds, melting curve measurement Analysis method: The gene amount (Ct value) of the housekeeping gene ACT7 and the glycyrrhizin synthesis-related gene group (6 types) was measured. The expression amount of each glycyrrhizin synthesis-related gene group was calculated using the ddCt method {2^-(each glycyrrhizin synthesis gene amount group-housekeeping gene amount)}.
[0129] <Result> Figure 4 shows the expression levels of the glycyrrhizin biosynthesis pathway and the glycyrrhizin synthesis-related genes involved in the biosynthesis pathway in the control group and the extract, the compound A derived from Solidago altissima, the compound B derived from Hosobaokera and Shinaokera, and the compound C derived from Artemisia capillaris. In the glycyrrhizin synthesis-related genes in Figure 4, the gene expression is significantly increased in the extract, the compound A derived from Solidago altissima, the compound B derived from Hosobaokera and Shinaokera, and the compound C derived from Artemisia capillaris, and is indicated by a red up arrow and a blue down arrow, respectively. As a result, the gene CYP72A154, which acts directly on glycyrrhizin synthesis, was significantly increased in expression in the extract and all of compounds A, B, and C compared to the control group. In the gene bAS upstream of glycyrrhizin synthesis, the expression was significantly increased in only compound A compared to the control group, but there was no change in the extract and compounds B and C compared to the control group. As with bAS, the expression of the gene CYP93E3 involved in the synthesis of soyasaponin was significantly increased with compound A alone compared to the control group, but there was no change compared to the control group with the extract and compounds B and C. In addition, the expression of the gene CYP716A179 involved in the synthesis of oleanolic acid and betulinic acid was significantly decreased with compound A alone compared to the control group, but there was no change compared to the control group with the extract and compounds B and C.
[0130] Test Example 6 An activity test was carried out to evaluate the metabolite content regulating activity of the extract used in Test Example 1 and the compound A derived from Solidago altissima used in Test Example 3 in plants other than licorice (arugula, radish, and garlic). The activity evaluation was carried out using metabolome analysis (LC-MS and GC-MS) that can comprehensively verify secondary and primary metabolites, and all secondary and primary metabolites were used as indicators. The specific method is as follows.
[0131] <Test Example 6-1. Plant growth conditions> Arugula (Eruca vesicaria) seeds, radish (Raphanus sativus) seeds, and garlic (Allium sativum) bulbs were surface-sterilized with 10% sodium hypochlorite solution for 5 min three times and washed with sterile water three times. The sterilized seeds were sown on MS medium (FUJIFILM Wako) containing 0.5% sucrose, 2.00 mg / L glycine, 100 mg / L myo-inositol, 0.50 mg / L nicotinic acid, 0.50 mg / L pyridoxine hydrochloride, 0.10 mg / L thiamine hydrochloride, 0.8% agar, and adjusted to pH 5.7. The germinated seeds were transferred to MS medium containing 3% sucrose, 2.00 mg / L glycine, 100 mg / L myo-inositol, 0.50 mg / L nicotinic acid, 0.50 mg / L pyridoxine hydrochloride, 0.10 mg / L thiamine hydrochloride, 0.8% agar, and pH 5.7. Germination and cultivation were carried out at a temperature of approximately 25°C and under a 16 / 8 hour light / dark cycle.
[0132] <Test Example 6-2. Activity test> Sterilized arugula and radish seeds and garlic bulbs were transplanted into MS medium (compound-added group) to which the extract and compound A derived from Solidago altissima were added at a concentration of 10 ppm, and into control MS medium (control group) to which the compounds were not added, and cultured for 2 to 4 weeks.
[0133] After cultivation, the arugula, radish and garlic were separated into above-ground parts and roots, and only the above-ground parts were weighed, frozen in liquid nitrogen and crushed. 2 mL of a mixed solution of MeOH-CHCl3-H2O (2.5:1:1) was added per 32 mg of plant body weight, and the mixture was centrifuged to obtain the supernatant. Next, 1 mL of a mixed solution of MeOH-CHCl3 (1:1) was added, and the mixture was centrifuged to obtain the supernatant. 0.5 mL of water was added to the combined solution of the two supernatants, mixed, and centrifuged, and the upper layer was analyzed by LC-MS and the lower layer by GC-MS. The analytical equipment and analytical conditions are as follows. LC-MS instrument: Shimadzu LC-IT-TOF mass spectrometer equipped with an ESI interface. ESI parameters: voltage, +4.5 kV (positive ion mode) and -3.5 kV (negative ion mode); capillary temperature, 200°C; nebulizer gas flow rate, 1.5 L / min. GC-MS equipment: Shimadzu 2010 GC-MS system (Shimadzu, Kyoto, Japan) equipped with a DB-5MS capillary column (0.25 mm × 30 m, 0.25 μm film thickness, Agilent Technologies, CA). Injector temperature, 270°C; transfer line and ion source, 300°C; oven temperature, 50°C~300°C (10°C / min). ·LC-MS conditions: Measurement range m / z 150 to 1500. Ion accumulation time 100 ms. ·HPLC conditions: Column A Waters Atlantis T3 column (2.1 mm id × 150 mm, 5 μm). Column temperature 40℃. Mobile phase (A) 5 mM ammonium acetate solution (B) acetonitrile. Gradient conditions: 0-30 min, linear gradient from 10 to 100% B, and 30-40 min, isocratic at 100% B. Flow rate 0.2 mL / min. GC-MS conditions: carrier gas, helium (1 mL / min); ion energy, 70 eV and 60 μA. Peak annotation: NIST 11 Mass Spectral Library and the Wiley Registry of Mass Spectral Data 9th Edition were used.
[0134] <Result> The main metabolite amounts that changed in the control group and the groups to which the extract and Solidago altissima-derived compound A were added, as well as the plant weights of each group, are shown in Figure 5. In arugula cultured for 3 weeks, the palmitic acid content was significantly increased in the groups to which the extract and Solidago altissima-derived compound A were added ( *** p< 0.001). In the radish plants cultured for two weeks, the content of lafasatin (a precursor of isothiocyanate) was significantly increased in the group treated with compound A derived from Solidago altissima ( * p< 0.05). In garlic cultured for 2 and 4 weeks, the content of allyl disulfide (precursor of allicin) was significantly increased in the extract and Solidago altissima-derived compound A-added groups ( * p< 0.05, ** p< 0.01). No significant difference was observed in the weight change of the plant body for arugula, radish, and garlic. Table 3 shows the metabolites whose contents were significantly changed in the groups that received the extract or compound A derived from Solidago altissima.
[0135] [Table 3]
Claims
1. General formula (1): [In the formula: R 1 R represents a hydrocarbon group which may be partially substituted with an ester group, a carbonyl group, or an oxygen atom. 2 represents a hydrocarbon group which may be partially substituted with an ester group, a carbonyl group, or an oxygen atom. A plant metabolite content regulator comprising at least one compound selected from the group consisting of compounds represented by the following formula (I):
2. The compound has the general formula (2): [In the formula: R 2 is the same as above. 11 , R 12 , R 13 R represents a hydrocarbon group which may be partially substituted with an ester group, a carbonyl group or an oxygen atom, or a hydrogen atom. 11 and R 13 may be bonded to form a ring. The metabolite content regulator according to claim 1, comprising at least one compound selected from the group consisting of compounds represented by the formula:
3. R 11 and the above R 13 The metabolite content regulator according to claim 2 , wherein when bonded to form a ring, is an alicyclic hydrocarbon group.
4. The compound has the general formula (3): [In the formula: R 2 is the same as above. 111 R represents an alkyl group. 21 represents a hydrocarbon group which may be partially substituted with an ester group, a carbonyl group, or an oxygen atom. The metabolite content regulator according to claim 1 , which is a compound represented by the formula:
5. The compound has the general formula (4): [In the formula: R 111 R represents an alkyl group. 22 represents a hydrocarbon group partially substituted with an ester group, or an alkyl group. The metabolite content regulator according to claim 1 , which is a compound represented by the formula:
6. The compound has the general formula (5): [In the formula: R 111 R represents an alkyl group. 221 represents a linear unsaturated hydrocarbon group. The metabolite content regulator according to claim 1 , which is a compound represented by the formula:
7. The metabolite content regulator according to any one of claims 1 to 6, wherein the compound is a plant-derived substance.
8. The metabolite content regulator according to claim 7 , wherein the plant-derived substance is any one of substances derived from plants of the genus Goldenrod, the genus Ophiopogon, and the genus Artemisia.
9. The metabolite content regulator according to any one of claims 1 to 6, wherein the metabolite is at least one selected from the group consisting of terpenoid compounds, sulfur compounds, and their glycosides, and fatty acids.
10. The metabolite content regulator according to claim 9, wherein the terpenoid compound is at least one selected from the group consisting of glycyrrhizin (pharmacopoeia name: glycyrrhizic acid) and its glycosides, or the group consisting of vitamins E and K and precursors of vitamins E and K.
11. The metabolite content regulator according to claim 9, wherein the sulfur compound is at least one selected from the group consisting of allicin and precursors and decomposition products of allicin, or the group consisting of isothiocyanates and precursors and decomposition products of isothiocyanates.
12. The metabolite content regulator according to claim 9, wherein the fatty acid is at least one selected from the group consisting of oleic acid and palmitic acid.
13. The metabolite content regulator according to any one of claims 1 to 6, wherein the target plants are medicinal plants and vegetables.
14. The metabolite content regulator according to claim 13, wherein the target medicinal plant is licorice and the target vegetables are arugula, radish, and garlic.
15. A method for regulating a metabolite content in a plant, comprising applying the metabolite content regulator according to any one of claims 1 to 6 to the plant.
16. A method for producing a plant having a regulated metabolite content, comprising applying the metabolite content regulator according to any one of claims 1 to 6 to the plant.
17. The method of claim 16, further comprising harvesting the plant having the regulated metabolite content.
18. A plant with regulated metabolite content, obtainable by the production method described in claim 16.
19. General formula (1): [In the formula: R 1 R represents a hydrocarbon group which may be partially substituted with an ester group, a carbonyl group, or an oxygen atom. 2 represents a hydrocarbon group which may be partially substituted with an ester group, a carbonyl group, or an oxygen atom. and a solvate thereof, and the metabolite content is adjusted as compared with a plant not containing said component.
Citation Information
Patent Citations
Methods to increase the production of secondary metabolites in plants
JP4686716B2
